BioMarin Pharmaceutical Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2010 | $545.4M | $1.26B | $88.1M |
| FY2011 | $532.7M | $1.31B | $46.3M |
| FY2012 | $552.6M | $1.57B | $180.5M |
| FY2013 | $903.0M | $2.24B | $568.8M |
| FY2014 | $947.5M | $2.48B | $875.5M |
| FY2015 | $1.33B | $3.73B | $397.0M |
| FY2016 | $1.26B | $4.02B | $408.3M |
| FY2017 | $1.82B | $4.63B | $598.0M |
| FY2018 | $1.46B | $4.43B | $494.0M |
| FY2019 | $1.57B | $4.69B | $437.4M |